Published in Am Heart J on January 01, 2011
Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms | NCT00332644
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA (2013) 4.81
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol (2012) 3.11
Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J (2014) 1.57
Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt. Ann Behav Med (2012) 1.12
The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab (2012) 0.95
Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial. Am Heart J (2011) 0.95
Are investments in disease prevention complements? The case of statins and health behaviors. J Health Econ (2014) 0.93
Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three-year outcomes after a quit attempt. PLoS One (2014) 0.92
The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes. Biomark Res (2013) 0.91
Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial. PLoS One (2012) 0.83
High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction. PLoS One (2013) 0.83
The role of lipotoxicity in smoke cardiomyopathy. PLoS One (2014) 0.83
Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease. Int J Clin Exp Med (2015) 0.77
The Association of Tobacco Use and Gender to Cardiac Rehabilitation Outcomes: A Preliminary Investigation. J Subst Use (2014) 0.76
Weight Gain After Smoking Cessation and Atherosclerotic Low-Density Lipoprotein Marker. J Atheroscler Thromb (2016) 0.75
Effects of Astrocaryum aculeatum Meyer (Tucumã) on Diet-Induced Dyslipidemic Rats. J Nutr Metab (2014) 0.75
Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes. BMC Res Notes (2017) 0.75
Efficacy of Resistance Training as an Aid to Smoking Cessation: Rationale and Design of the Strength To Quit Study. Ment Health Phys Act (2014) 0.75
Dyslipidemia Management for Secondary Prevention in Women with Cardiovascular Disease: What Can We Expect From Non-pharmacologic Strategies? Curr Cardiovasc Risk Rep (2012) 0.75
Treatment of dyslipidemia. F1000Prime Rep (2014) 0.75
Very low nicotine content cigarettes and potential consequences on cardiovascular disease. Curr Cardiovasc Risk Rep (2012) 0.75
The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction. J Transl Med (2016) 0.75
Electrocardiographic changes associated with smoking and smoking cessation: outcomes from a randomized controlled trial. PLoS One (2013) 0.75
Association of Air Pollution Exposures With High-Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2017) 0.75
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk. Front Neurol (2017) 0.75
Smokers and Postcessation Weight Gain After Acute Coronary Syndrome. J Am Heart Assoc (2017) 0.75
International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc (2003) 47.83
Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ (2004) 24.88
Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation (1989) 9.97
The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol (2004) 6.44
Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict (1988) 6.20
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med (2006) 4.91
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66
The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med (1995) 3.39
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr (1992) 2.78
Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis (2003) 2.75
Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome. Nicotine Tob Res (2001) 2.52
Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev (2008) 2.11
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis (2008) 1.92
Reliability of adult retrospective recall of lifetime tobacco use. Nicotine Tob Res (2008) 1.70
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
State-specific prevalence of obesity among adults--United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 1.48
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis (1994) 1.40
The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol (1993) 1.38
Estimating the effect of smoking cessation on weight gain: an instrumental variable approach. Health Serv Res (2006) 1.21
The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med (2003) 1.19
Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol (2009) 1.19
Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation (1980) 1.11
Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. J Addict Dis (2005) 1.11
Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. Am Heart J (2010) 1.10
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Arch Intern Med (2009) 1.06
Modification of LCAT activity and HDL structure. New links between cigarette smoke and coronary heart disease risk. Arterioscler Thromb (1994) 1.04
Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest (1993) 1.04
Smoking and diabetes differ in their associations with subclinical atherosclerosis and coronary heart disease-the ARIC Study. Atherosclerosis (2004) 1.03
The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest (1998) 0.98
Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport. Metabolism (2004) 0.91
Risk factors for subclinical carotid atherosclerosis among current smokers. Prev Cardiol (2010) 0.87
A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials. Addict Behav (2008) 0.84
Smoking and small, dense low-density lipoprotein particles: cross-sectional study. Nicotine Tob Res (2008) 0.80
Low-to-moderate alcohol consumption and smoking cessation rates: retrospective analysis of 4576 elderly ever-smokers. Drug Alcohol Depend (2010) 0.78
Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66
A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health (2004) 3.71
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol (2008) 3.36
Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst (2004) 3.26
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15
Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation (2007) 2.82
Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med (2005) 2.80
Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res (2006) 2.77
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Prevalence and predictors of transitions in smoking behavior among college students. Health Psychol (2004) 2.64
Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction (2002) 2.48
New methods for tobacco dependence treatment research. Ann Behav Med (2011) 2.44
The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43
Does detection of carotid plaque affect physician behavior or motivate patients? Am Heart J (2007) 2.33
Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30
Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Am J Epidemiol (2012) 2.23
Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol (2002) 2.18
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation (2008) 2.17
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02
Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest (2002) 2.02
Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res (2006) 2.02
Clinical practice. Treating smokers in the health care setting. N Engl J Med (2011) 1.99
Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med (2009) 1.95
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86
Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res (2009) 1.84
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol (2003) 1.79
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol (2008) 1.72
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine Tob Res (2008) 1.70
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol (2003) 1.64
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res (2010) 1.63
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 1.60
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction (2010) 1.60
Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60
Smoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations. Am J Public Health (2008) 1.57
A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med (2007) 1.55
The role of health care systems in increased tobacco cessation. Annu Rev Public Health (2008) 1.53
Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med (2012) 1.52
Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol (2005) 1.50
Smoker characteristics and smoking-cessation milestones. Am J Prev Med (2011) 1.47
Cardiovascular risks of antiretroviral therapy. N Engl J Med (2007) 1.45
Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: the Bogalusa Heart Study. Ann Intern Med (2005) 1.44
A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One (2012) 1.44
Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. JAMA Psychiatry (2013) 1.38
Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke (2007) 1.38
Efficacy of bupropion alone and in combination with nicotine gum. Nicotine Tob Res (2007) 1.33
Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol (2011) 1.33
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol (2003) 1.33